![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:ANP32E-LAMTOR5 (FusionGDB2 ID:HG81611TG10542) |
Fusion Gene Summary for ANP32E-LAMTOR5 |
![]() |
Fusion gene information | Fusion gene name: ANP32E-LAMTOR5 | Fusion gene ID: hg81611tg10542 | Hgene | Tgene | Gene symbol | ANP32E | LAMTOR5 | Gene ID | 81611 | 10542 |
Gene name | acidic nuclear phosphoprotein 32 family member E | late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 | |
Synonyms | LANP-L|LANPL | HBXIP|XIP | |
Cytomap | ('ANP32E')('LAMTOR5') 1q21.2 | 1p13.3 | |
Type of gene | protein-coding | protein-coding | |
Description | acidic leucine-rich nuclear phosphoprotein 32 family member ELANP-like proteinacidic (leucine-rich) nuclear phosphoprotein 32 family, member Eleucine-rich acidic nuclear protein like | ragulator complex protein LAMTOR5HBV X-interacting proteinHBx-interacting proteinhepatitis B virus x interacting proteinhepatitis B virus x-interacting protein (9.6kD)late endosomal/lysosomal adaptor and MAPK and MTOR activator 5 | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | Q9BTT0 | . | |
Ensembl transtripts involved in fusion gene | ENST00000314136, ENST00000369114, ENST00000369115, ENST00000369116, ENST00000369119, ENST00000436748, ENST00000533654, | ||
Fusion gene scores | * DoF score | 5 X 5 X 3=75 | 2 X 2 X 2=8 |
# samples | 5 | 2 | |
** MAII score | log2(5/75*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/8*10)=1.32192809488736 | |
Context | PubMed: ANP32E [Title/Abstract] AND LAMTOR5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ANP32E(150195512)-LAMTOR5(110950316), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ANP32E | GO:0043486 | histone exchange | 24463511 |
Tgene | LAMTOR5 | GO:0043066 | negative regulation of apoptotic process | 12773388 |
Tgene | LAMTOR5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 21343296 |
Tgene | LAMTOR5 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 12773388 |
Tgene | LAMTOR5 | GO:1900182 | positive regulation of protein localization to nucleus | 21343296 |
Tgene | LAMTOR5 | GO:1905636 | positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding | 21343296 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-HU-A4GT-01A | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
Top |
Fusion Gene ORF analysis for ANP32E-LAMTOR5 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000314136 | ENST00000256644 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-5UTR | ENST00000314136 | ENST00000602318 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-5UTR | ENST00000369114 | ENST00000256644 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-5UTR | ENST00000369114 | ENST00000602318 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-5UTR | ENST00000369115 | ENST00000256644 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-5UTR | ENST00000369115 | ENST00000602318 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-5UTR | ENST00000369116 | ENST00000256644 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-5UTR | ENST00000369116 | ENST00000602318 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-5UTR | ENST00000369119 | ENST00000256644 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-5UTR | ENST00000369119 | ENST00000602318 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-5UTR | ENST00000436748 | ENST00000256644 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-5UTR | ENST00000436748 | ENST00000602318 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000314136 | ENST00000474861 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000314136 | ENST00000483260 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000314136 | ENST00000602858 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000369114 | ENST00000474861 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000369114 | ENST00000483260 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000369114 | ENST00000602858 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000369115 | ENST00000474861 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000369115 | ENST00000483260 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000369115 | ENST00000602858 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000369116 | ENST00000474861 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000369116 | ENST00000483260 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000369116 | ENST00000602858 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000369119 | ENST00000474861 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000369119 | ENST00000483260 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000369119 | ENST00000602858 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000436748 | ENST00000474861 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000436748 | ENST00000483260 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
5CDS-intron | ENST00000436748 | ENST00000602858 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
intron-5UTR | ENST00000533654 | ENST00000256644 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
intron-5UTR | ENST00000533654 | ENST00000602318 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
intron-intron | ENST00000533654 | ENST00000474861 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
intron-intron | ENST00000533654 | ENST00000483260 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
intron-intron | ENST00000533654 | ENST00000602858 | ANP32E | chr1 | 150195512 | - | LAMTOR5 | chr1 | 110950316 | - |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for ANP32E-LAMTOR5 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for ANP32E-LAMTOR5 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:150195512/:110950316) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
ANP32E | . |
FUNCTION: Histone chaperone that specifically mediates the genome-wide removal of histone H2A.Z/H2AZ1 from the nucleosome: removes H2A.Z/H2AZ1 from its normal sites of deposition, especially from enhancer and insulator regions. Not involved in deposition of H2A.Z/H2AZ1 in the nucleosome. May stabilize the evicted H2A.Z/H2AZ1-H2B dimer, thus shifting the equilibrium towards dissociation and the off-chromatin state (PubMed:24463511). Inhibits activity of protein phosphatase 2A (PP2A). Does not inhibit protein phosphatase 1. May play a role in cerebellar development and synaptogenesis. {ECO:0000269|PubMed:24463511}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for ANP32E-LAMTOR5 |
![]() |
Top |
Fusion Gene PPI Analysis for ANP32E-LAMTOR5 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ANP32E-LAMTOR5 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ANP32E-LAMTOR5 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | C0006142 | Malignant neoplasm of breast | 1 | CTD_human | |
Tgene | C0271650 | Impaired glucose tolerance | 1 | CTD_human | |
Tgene | C0678222 | Breast Carcinoma | 1 | CTD_human | |
Tgene | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human | |
Tgene | C1458155 | Mammary Neoplasms | 1 | CTD_human | |
Tgene | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |